Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Report Publication Announcement 2024

Aug 26, 2024

6785_rns_2024-08-26_0d247bdc-ec9c-43d9-a21d-7a49d6992134.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 381
EVOGENE LTD
Corporation no: 512838723 14299
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 26/08/2024
www.isa.gov.il www.tase.co.il Reference: 2024-02-093634 Time of broadcast: 09:20 09:20

Amended report for distorted report sent on date 23/08/2024 Whose reference number was: 2024-02-087345

The distortion: Accessible version
The distortion cause: Accessibility company does not work during the weekend
The main amendment: Accessible version

The corporation scheduled the publication of the report to 26/08/2024 09:35Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Prospectus Supplement

ProSupp_Lake_Street_Accessible_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 06/08/2024
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1